Genetic embryo testing for hereditary disorders (PGT-M)

Embryo screening to identify specific genetic mutations associated with serious monogenic diseases such as cystic fibrosis or Huntington’s disease. This method helps couples with a genetic burden reduce the risk of passing on the inherited disease to their child. PGT-M allows us to select embryos without the given mutation, increasing the chance of having a healthy child.